Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6228]

Programming cells to target brain tumours

Programming cells to target brain tumours

Unexpected immune response may hold key to long-term cancer remission

Unexpected immune response may hold key to long-term cancer remission

Metabolic reprogramming of T cells may enhance checkpoint inhibitor therapy

Metabolic reprogramming of T cells may enhance checkpoint inhibitor therapy

SWOG S1712 supports adding ruxolitinib to TKIs for chronic myeloid leukaemia

SWOG S1712 supports adding ruxolitinib to TKIs for chronic myeloid leukaemia

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain paediatric leukaemia subtypes

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain paediatric leukaemia...

New cancer cachexia treatment boosts weight gain and patient activity

New cancer cachexia treatment boosts weight gain and patient activity

Non-invasive method to predict survival in patients with liver cancer

Non-invasive method to predict survival in patients with liver cancer

WCC 2024: Eliminating 5% of all cancers globally could be a reality with today's announcement calling for global gender-neutral HPV vaccination by 2030

WCC 2024: Eliminating 5% of all cancers globally could be a reality with today's announcement calling for global...

WCLC 2024: Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung cancer treated with intravenous amivantamab-vmjw

WCLC 2024: Dexamethasone reduces infusion-related reactions in patients with EGFR-mutated non-small cell lung...

FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma

FDA approves pembrolizumab with chemotherapy for unresectable advanced or metastatic malignant pleural mesothelioma

More from ecancer